RNS Number : 8741D
Experian plc
28 June 2019

Experian plc



Share repurchases



28 June 2019 - Experian plc (the Company), the global information services company, hereby notifies the market that, in continuation of the share repurchase programme announced by the Company on 15 May 2019, it has entered into an irrevocable and non-discretionary arrangement with its broker, J.P. Morgan Securities plc, to purchase on its behalf and within certain pre-set parameters, ordinary shares of 10 US cents each in the Company during the Company's closed period commencing on 1 July 2019 up to and including 12 July 2019. The Company's Q1 FY20 Trading Update is scheduled for release on 16 July 2019. The shares purchased will be cancelled.


This arrangement is in accordance with Chapter 12 of the UK Listing Authority Listing Rules and the Company's general authority to repurchase shares.







Ronan Hanna

Deputy Company Secretary

+353 (0) 1 846 9128


About Experian

Experian is the world's leading global information services company. During life's big moments - from buying a home or a car, to sending a child to college, to growing a business by connecting with new customers - we empower consumers and our clients to manage their data with confidence. We help individuals to take financial control and access financial services, businesses to make smarter decisions and thrive, lenders to lend more responsibly, and organisations to prevent identity fraud and crime.


We have 17,200 people operating across 44 countries and every day we're investing in new technologies, talented people and innovation to help all our clients maximise every opportunity. We are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.


Learn more at or visit our global content hub at our global news blog for the latest news and insights from the Group.




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit